RNAC 股东权益历史(2016–2025)
Cartesian Therapeutics, Inc. (RNAC) 各财年年末股东权益(来自 SEC 财报)。
-$126.2MFY2025 · FY2016 以来:$55.0M → -$126.2M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$126.2M | -1755.9% |
| FY2024 | -$6.8M | +98.5% |
| FY2023 | -$440.2M | -569.1% |
| FY2022 | $93.8M | +316.6% |
| FY2021 | $22.5M | +225.1% |
| FY2020 | -$18.0M | -314.4% |
| FY2019 | $8.4M | +255.0% |
| FY2018 | -$5.4M | -110.5% |
| FY2017 | $51.8M | -5.7% |
| FY2016 | $55.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议